When ciprofloxacin was used to treat E. coli O104:H4 infections during the 2011 outbreak in Germany, the risk of HUS development did not increase (although only five patients were treated) [272], but O104:H4 STEC strain stx2-expression was shown to increase [273]. Here, STX2 is linked to hemolytic-uremic syndrome.